Brief: Regulus Therapeutics Enters Into Agreement To Be Acquired By Novartis AG
30/04/2025 12:15
April 30 (Reuters) - Regulus Therapeutics Inc RGLS.O: REGULUS THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED BY NOVARTIS AG REGULUS THERAPEUTICS INC - DEAL VALUED UP TO $1.7 BILLION WITH CONTINGENT VALUE RIGHT Source text: ID:nPn7dQYppa Further company coverage: RGLS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview